Table 3.

		N	%
Total		15	100.00
Age at time of surgery	Median (range)	62 (33–75)
Sex	Male	9	60.00
	Female	6	40.00
Race	Black/African American	2	13.33
	White/Caucasian	13	86.67
Histologic subtype	Clear cell RCC	11	73.33
	Other RCC	4	26.67
Treatment	Nivolumab	3	20.00
	Ipilimumab+nivolumab	9	60.00
	Study drug+ipilimumab+nivolumab	3	20.00
Histologic subtype	Clear cell RCC	11	73.33
	Other RCC	3	20.00
Stage at diagnosis	I	1	6.67
	II	0	0.00
	III	6	40.00
	IV	8	53.33

RCC, renal cell carcinoma.